Published in Am J Ther on May 06, 2016
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol (2002) 6.48
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2015) 4.85
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med (2009) 2.50
Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest (2005) 2.39
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet (2011) 2.38
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21
Proteinuria: an enzymatic disease of the podocyte? Kidney Int (2009) 2.17
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest (2007) 2.02
Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis. Transplantation (2012) 1.89
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol (2013) 1.83
Direct dynamin-actin interactions regulate the actin cytoskeleton. EMBO J (2010) 1.67
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal (2011) 1.51
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest (2011) 1.49
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation. Transplantation (2015) 1.47
A novel TRPC6 mutation that causes childhood FSGS. PLoS One (2009) 1.47
Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J Biol Chem (2008) 1.43
Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest (2010) 1.34
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int (2013) 1.33
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2014) 1.26
Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25
Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res (2010) 1.23
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One (2010) 1.18
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17
TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol (2010) 1.14
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol (2014) 1.02
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) (2012) 1.02
Novel siRNA delivery system to target podocytes in vivo. PLoS One (2010) 0.96
Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol (2011) 0.96
Podocyte GTPases regulate kidney filter dynamics. Kidney Int (2012) 0.96
Organizational and cultural changes for providing safe patient care. Qual Manag Health Care (2005) 0.95
Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest (2014) 0.94
Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol (2008) 0.94
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation (2013) 0.92
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem (2013) 0.89
Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis (2012) 0.88
Role of podocytes in lupus nephritis. Nephrol Dial Transplant (2009) 0.88
Is there clinical value in measuring suPAR levels in FSGS? Clin J Am Soc Nephrol (2013) 0.87
The genetic basis of human glomerular disease. Adv Chronic Kidney Dis (2006) 0.87
Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release. Diabetes (2009) 0.87
Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis (2011) 0.86
Minimal change disease as a modifiable podocyte paracrine disorder. Nephrol Dial Transplant (2011) 0.86
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther (2013) 0.85
TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease. Pediatr Nephrol (2010) 0.85
CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation. Nefrologia (2013) 0.83
In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma (Larchmt) (2011) 0.82
C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells (2013) 0.82
Establishment of protein delivery systems targeting podocytes. PLoS One (2010) 0.82
Filtering new facts about kidney disease. Nat Med (2011) 0.82
Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant (2012) 0.81
Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis (2012) 0.81
Cellular effects of everolimus and sirolimus on podocytes. PLoS One (2013) 0.80
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization. J Pathol (2015) 0.80
Enzymatic disease of the podocyte. Pediatr Nephrol (2010) 0.80
Novel concepts in understanding and management of glomerular proteinuria. Nephrol Dial Transplant (2002) 0.80
Regarding Maas's editorial letter on serum suPAR levels. Kidney Int (2012) 0.78
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrol Dial Transplant (2012) 0.78
Circulating factor in FSGS: a black sheep in the suPAR family? Pediatr Nephrol (2013) 0.78
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2016) 0.77
Maximal 'CD80-uria' with minimal change. Kidney Int (2010) 0.77
Expression of trpC1 and trpC6 orthologs in zebrafish. Gene Expr Patterns (2008) 0.76
Fishing for new glomerular disease-related genes. J Am Soc Nephrol (2011) 0.76
TRPC6 in podocytes: questions and commentary on the article by Jiang et al., 'Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca21 and RhoA activation'. Exp Biol Med (Maywood) (2011) 0.75
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest (2017) 0.75
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Pediatr Nephrol (2014) 0.75
Determining medical error. Three case reports. Eff Clin Pract (2002) 0.75
Patient safety intervention to reduce unnecessary red blood cell utilization. Am J Manag Care (2016) 0.75
Why blame systems for unsafe care? Lancet (2004) 0.75
The hospital is not your home: making safety safer (Swiss cheese is a culinary missed metaphor). Qual Manag Health Care (2011) 0.75
Effects of training on a simulator of pain care on the quality of pain care for patients with cancer-related pain. Qual Manag Health Care (2008) 0.75
Computer-based simulation as a teaching tool for residents treating patients with cancer-related pain crises. Qual Manag Health Care (2008) 0.75
An exploratory analysis of the correlation of pain scores, patient satisfaction with relief from pain, and a new measure of pain control on the total dose of opioids in pain care. Qual Manag Health Care (2013) 0.75
Is podocyte research at a tipping point? Report from the 9(th) International Podocyte Conference. Kidney Int (2012) 0.75